📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

HLA restriction of carbamazepine-specific T-Cell clones from an HLA-A*31:01-positive hypersensitive patient. (2014)

First Author: Lichtenfels M

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/tx400460w

PubMed Identifier: 24476427

Publication URI: http://europepmc.org/abstract/MED/24476427

Type: Journal Article/Review

Volume: 27

Parent Publication: Chemical research in toxicology

Issue: 2

ISSN: 0893-228X